IT1223290B - Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche - Google Patents

Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche

Info

Publication number
IT1223290B
IT1223290B IT21453/87A IT2145387A IT1223290B IT 1223290 B IT1223290 B IT 1223290B IT 21453/87 A IT21453/87 A IT 21453/87A IT 2145387 A IT2145387 A IT 2145387A IT 1223290 B IT1223290 B IT 1223290B
Authority
IT
Italy
Prior art keywords
vasocinetic
action
polyunsaturated acids
cosmetic formulations
related pharmaceutical
Prior art date
Application number
IT21453/87A
Other languages
English (en)
Other versions
IT8721453A0 (it
Inventor
Ezio Bombardelli
Sergio B Curri
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Priority to IT21453/87A priority Critical patent/IT1223290B/it
Publication of IT8721453A0 publication Critical patent/IT8721453A0/it
Priority to EP88111306A priority patent/EP0304603B1/en
Priority to ES88111306T priority patent/ES2052645T3/es
Priority to AT88111306T priority patent/ATE81588T1/de
Priority to DE8888111306T priority patent/DE3875425T2/de
Application granted granted Critical
Publication of IT1223290B publication Critical patent/IT1223290B/it
Priority to US07/670,349 priority patent/US5104655A/en
Priority to GR920402391T priority patent/GR3006068T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544Phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IT21453/87A 1987-07-27 1987-07-27 Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche IT1223290B (it)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IT21453/87A IT1223290B (it) 1987-07-27 1987-07-27 Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche
EP88111306A EP0304603B1 (en) 1987-07-27 1988-07-14 Polyunsaturated acids having vasokinetic action and pharmaceutical and cosmetic formulations containing them
ES88111306T ES2052645T3 (es) 1987-07-27 1988-07-14 Acidos poliinsaturados con accion vasocinetica y formulaciones farmaceuticas y cosmeticas que los contienen.
AT88111306T ATE81588T1 (de) 1987-07-27 1988-07-14 Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen.
DE8888111306T DE3875425T2 (de) 1987-07-27 1988-07-14 Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen.
US07/670,349 US5104655A (en) 1987-07-27 1991-03-15 Polyunsaturated acids having vasokinetic action and pharmaceutical and cosmetic formulations containing them
GR920402391T GR3006068T3 (it) 1987-07-27 1992-10-23

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT21453/87A IT1223290B (it) 1987-07-27 1987-07-27 Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche

Publications (2)

Publication Number Publication Date
IT8721453A0 IT8721453A0 (it) 1987-07-27
IT1223290B true IT1223290B (it) 1990-09-19

Family

ID=11181998

Family Applications (1)

Application Number Title Priority Date Filing Date
IT21453/87A IT1223290B (it) 1987-07-27 1987-07-27 Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche

Country Status (7)

Country Link
US (1) US5104655A (it)
EP (1) EP0304603B1 (it)
AT (1) ATE81588T1 (it)
DE (1) DE3875425T2 (it)
ES (1) ES2052645T3 (it)
GR (1) GR3006068T3 (it)
IT (1) IT1223290B (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0693278A3 (en) * 1994-07-19 1996-11-06 Indena Spa Combinations of vasoactive substances with fatty acids to prevent hair loss

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4006563C2 (de) * 1988-09-02 1994-06-30 Reutter Werner Verwendung von Phosphatesterderivaten als Wirkstoffe in Kosmetika und sie enthaltende kosmetische Präparate
DE4022815A1 (de) * 1990-07-18 1992-01-23 Braun Melsungen Ag Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer hauterkrankungen
DE4042437A1 (de) * 1990-07-18 1992-06-11 Braun Melsungen Ag Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer verbrennungen
WO1992011036A1 (en) * 1990-12-21 1992-07-09 Wade, Jonathan, Leslie Adjuvants containing unsaturated lipid
SE9101642D0 (sv) * 1991-05-30 1991-05-30 Kabi Pharmacia Ab Phospholipids
IT1251497B (it) * 1991-09-18 1995-05-15 Mivett Nuovi Lab Di Pavani& C Uso di 1,2 dipalmitoil-l-alfa-fosfatidil-n,n-dimetiletanolammina, in composizioni dermatologiche
IT1251840B (it) * 1991-09-20 1995-05-26 Schiena Ricerche Uso di formulazioni liposomiali contenenti papaverina nel trattamento della impotenza maschile
FR2698269B1 (fr) * 1992-11-24 1995-01-06 Inst Nat Sante Rech Med Nouveaux médicaments à base d'acides gras insaturés, utilisables notamment comme antiagrégants plaquettaires et/ou comme transporteurs privilégiés vers le cerveau.
CN1105852A (zh) * 1993-08-25 1995-08-02 株式会社巴依奥克斯 皮肤营养物及含皮肤营养物的化妆品组合物
US5411988A (en) * 1993-10-27 1995-05-02 Bockow; Barry I. Compositions and methods for inhibiting inflammation and adhesion formation
IT1269634B (it) * 1994-05-06 1997-04-08 Indena Spa Medicamento topico ad attivita' cicatrizzante
DE69637953D1 (de) * 1995-04-17 2009-07-30 Nat Inst Of Advanced Ind Scien Hoch ungesättigte fettsäurenproduzierende mikroorganismen und verfahren zur herstellung von hoch ungesättigten fettsäuren durch verwendung dieser mikroorganismen
FR2741533B1 (fr) * 1995-11-28 1998-02-06 Grinda Jean Robert Procede de stabilisation des acides gras polyinsatures et utilisation de ces produits stabilises en cosmetologie
IT1284971B1 (it) * 1996-10-17 1998-05-28 Indena Spa Formulazioni farmaceutiche e cosmetiche ad attivita' antiacne
US6267996B1 (en) 1996-10-17 2001-07-31 Indena S.P.A Pharmaceutical and cosmetic formulations with antimicrobial activity
TW592719B (en) * 1997-03-26 2004-06-21 Shiseido Co Ltd Hair growth phase extender composition containing unsaturated fatty acid and/or its derivatives or an extract of a plant belonging to the Coriandrum
US8039026B1 (en) * 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
GB2331528B (en) * 1997-11-20 2002-03-13 Unilever Plc Hair treatment composition
US8106094B2 (en) * 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8093293B2 (en) * 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US20020197244A1 (en) * 1998-12-07 2002-12-26 Miri Seiberg Compositions and methods for regulating phagocytosis and ICAM-1 expression
US7985404B1 (en) * 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
GB9918023D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Skin care composition
US7309688B2 (en) * 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
GB0004686D0 (en) * 2000-02-28 2000-04-19 Aventis Pharma Ltd Chemical compounds
US8431550B2 (en) * 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
US7192615B2 (en) * 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
ITMI20011182A1 (it) * 2001-06-05 2002-12-05 Indena Spa Composizioni farmaceutiche e/o cosmetiche per il trattamento di adiposita' localizzate e della cellulite
US20030224075A1 (en) * 2002-02-21 2003-12-04 Jue-Chen Liu Soy composition for balancing combination skin
EP1402787A1 (en) 2002-09-27 2004-03-31 Loders Croklaan B.V. Ximenynic acid
KR20050083960A (ko) * 2002-11-22 2005-08-26 닛폰 스이산 가부시키가이샤 고도 불포화 지방산, 그 염, 또는 그 에스테르를 함유하는외용 조성물
US20050004561A1 (en) * 2003-07-01 2005-01-06 Lynn Halas Method for removing hair
ITMI20031428A1 (it) * 2003-07-11 2005-01-12 Indena Spa Combinazioni di agenti vasoattivi e loro uso per il trattamento di disfunzioni sessuali
EP1677748A1 (en) * 2003-10-29 2006-07-12 Johnson & Johnson Consumer France SAS Compositions comprising soy products and dioic acids
US20050158258A1 (en) * 2004-01-21 2005-07-21 Mary Kay Inc. Methods and compositions for the treatment of skin changes associated with aging and environmental damage
DE102005061071A1 (de) * 2005-12-21 2007-06-28 Kneipp-Werke Kneipp-Mittel-Zentrale Gmbh & Co. Kg Wirkstoffkombination aus Santalbinsäure oder Derivate davon und Traubenkernöl zur topischen oder dermatologischen Verwendung
US20080008818A1 (en) * 2006-06-23 2008-01-10 Miri Seiberg Partially denatured whole soybean extracts and methods of use thereof
US20080089960A1 (en) * 2006-10-16 2008-04-17 Miri Seiberg Use of Legume Products for the Treatment and Prevention of Radiotherapy-Induced Skin Damage
US20100173014A1 (en) * 2007-05-24 2010-07-08 Nanosolutions, Llc Methods of making and using nano scale particles
DE102008032327A1 (de) * 2008-07-09 2010-01-14 Rovi Cosmetics International Gmbh Kosmetisches oder pharmazeutisches Präparat zur topischen Applikation von mehrfach ungesättigten Fettsäuren

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444755A (en) * 1978-01-23 1984-04-24 Efamol Limited Treatment for skin disorders
DE2952115C2 (de) * 1979-12-22 1982-05-06 A. Nattermann & Cie GmbH, 5000 Köln Rosmarinsäure-Phospholipid-Komplex
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
FR2548021B1 (fr) * 1983-06-29 1986-02-28 Dick P R Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels
GB8319073D0 (en) 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0693278A3 (en) * 1994-07-19 1996-11-06 Indena Spa Combinations of vasoactive substances with fatty acids to prevent hair loss

Also Published As

Publication number Publication date
DE3875425T2 (de) 1993-03-11
IT8721453A0 (it) 1987-07-27
US5104655A (en) 1992-04-14
GR3006068T3 (it) 1993-06-21
DE3875425D1 (de) 1992-11-26
ATE81588T1 (de) 1992-11-15
EP0304603A1 (en) 1989-03-01
ES2052645T3 (es) 1994-07-16
EP0304603B1 (en) 1992-10-21

Similar Documents

Publication Publication Date Title
IT1223290B (it) Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche
DE3778699D1 (de) Verwendung von vitamin e zur herstellung von arzneimitteln zur normalisierung der blutgerinnung bei therapie mit hochungesaettigten fettsaeuren vom omega-3-typ.
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
FR2710527B1 (fr) Nouvelles compositions cosmétiques et dermatologiques associant céramides et acide linoléique, leur préparation.
ZA885192B (en) Pharmaceutical preparations
DE3486235T2 (de) Fettsäure-Zusammensetzungen.
ES2033442T3 (es) Procedimiento para preparar una composicion farmaceutica a base de acidos grasos.
ATE22532T1 (de) Pharmazeutische zusammensetzung.
DE3485337D1 (de) Topische zubereitungen mit gehalt an teer und fettsaeuren.
DK585889D0 (da) Farmaceutisk praeparat
DE68901105D1 (de) Alkensaeurederivate.
NO932843D0 (no) Farmasoeytiske preparater
SE8800988L (sv) Farmaceutiska kompositioner med verkan paa hjaertat och det kardiovaskulaera systemet samt foerfarande foer framstaellning av desamma
EP0378824A3 (en) Use of omega-3-fatty acids as anticachexia agents
OA08349A (fr) Acides propenylaminothiazolylcephalosporaniques 3-substitués et leurs esters.
FI891210A0 (fi) Tiosulfinsyraderivat, deras anvaendning vid inflammationssjukdomar samt laekemedel innehaollande dessa aemnen.
ATE19855T1 (de) Pharmazeutische und diaetetische zusammensetzung.
SE8705035L (sv) Anvaendning av alkylglycerol
IT1243358B (it) Composizioni farmaceutiche per la somministrazione orale di irudina
FI871695A0 (fi) Topiska, kardiovaskulaera produkter.
IT1227158B (it) Esteri dell'acido tiamorfolinone carbossilico e di suoi derivati, loro procedimento di preparazione e loro impiego nel settore cosmetico e nel settore dermo farmaceutico.
IT8719888A0 (it) Formulazioni farmaceutiche iniettabili di principi attivi adattivita' anestetica generale.
FI885277A (fi) 2,4-diklor-5-fluorbenzoyl -aettikssyraetylester.